Dr Mark Earl
Telephone:
Email:
Location:
- National Hospital for Neurology and Neurosurgery
GMC/GDC number:
7037437
Professional background
Dr Mark Earl is a consultant in neuroanaesthesia and neurocritical care at the National Hospital for Neurology and Neurosurgery.
He graduated from the School of Medicine at the University of Manchester in 2009, additionally receiving a Master of Research from the Faculty of Medical and Human Sciences. He has completed specialty training in the North Central London and Bart’s and The London Schools of Anaesthesia, with an advanced year in intensive care medicine at King’s College Hospital.
Dr Earl joined UCLH as a substantive consultant in 2023 and provides a regular neuro anaesthesia service for complex spine, intracranial, pituitary, and posterior fossa procedures, in addition to the provision of in-tensive care medicine for elective and emergency neurosciences patients.
Research interests
Neurocritical Care
Interventional Neuroradiology
Publications
Earl M, Reddy U. Traumatic brain injury: initial resuscitation and transfer. Anaesth. Intensive Care Med. 2023. 24(6): 329-332.
Earl M, Abid S, Appleby I, Reddy U. Anesthesia for Endovascular Neurosurgery. Curr Anesthesiol Rep. 2021. 11(3):1-11.
Raith EP, Luoma AMV, Earl M, Dalal M, Fairley S, Fox F, Hunt K, Willett C, Reddy U. Repurposing a Neurocritical Care Unit for the Management of Severely Ill Patients With COVID-19: A Retrospective Evaluation. J Neurosurg Anesthesiol. 2021 Jan;33(1):77-81.
Trigonis I, Koh PK, Taylor B, Tamal M, Ryder D, Earl M, Anton-Rodriguez J, Haslett K, Young H, Faivre-Finn C, Blackhall F, Jackson A, Asselin MC. Early reduction in tumour [18F] fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone. Eur J Nucl Med Mol Imaging. 2014. Apr;41(4):682-93.
Kalson N, Thompson J, Davies AJ, Stokes S, Earl MD, Whitehead A, Tyrrell-Marsh I, Frost H, Montgomery H. The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro. Eur J Appl Physiol. 2009 Feb;105(3):373-9.
Davies AJ, Kalson NS, Stokes S, Earl MD, Whitehead AG, Frost H, Tyrell-Marsh I, Naylor J. Determinants of summiting success and acute mountain sickness on Mt. Kilimanjaro (5895m). Wilderness Environ Med. 2009. Winter;20(4):311-7.